skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 13,229  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial
Material Type:
Article
Add to My Research

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial

Circulation (New York, N.Y.), 2020-01, Vol.141 (2), p.90-99 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2019 The Authors. 2019 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.044138 ;PMID: 31736335

Full text available

2
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation (New York, N.Y.), 2022-10, Vol.146 (16), p.1210-1224 [Peer Reviewed Journal]

2022 The Authors. 2022 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.061754 ;PMID: 36029465

Full text available

3
Effects of Serelaxin in Patients with Acute Heart Failure
Material Type:
Article
Add to My Research

Effects of Serelaxin in Patients with Acute Heart Failure

The New England journal of medicine, 2019-08, Vol.381 (8), p.716-726 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1801291 ;PMID: 31433919

Full text available

4
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction

Journal of the American College of Cardiology, 2023-02, Vol.81 (5), p.460-473 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2022.11.006 ;PMID: 36526515

Full text available

5
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Material Type:
Article
Add to My Research

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature medicine, 2022-12, Vol.28 (12), p.2504-2511 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;ISSN: 1546-170X ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02102-9 ;PMID: 36522606

Full text available

6
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
Material Type:
Article
Add to My Research

Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

European heart journal, 2021-01, Vol.42 (2), p.152-161 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa736 ;PMID: 33099609

Full text available

7
Inflammation in Heart Failure: JACC State-of-the-Art Review
Material Type:
Article
Add to My Research

Inflammation in Heart Failure: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.1324-1340 [Peer Reviewed Journal]

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2020.01.014 ;PMID: 32192660

Full text available

8
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial
Material Type:
Article
Add to My Research

Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial

Circulation (New York, N.Y.), 2021-01, Vol.143 (4), p.326-336 [Peer Reviewed Journal]

2020 The Authors. 2020 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.051783 ;PMID: 33081531

Full text available

9
Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic
Material Type:
Article
Add to My Research

Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic

Circulation (New York, N.Y.), 2020-08, Vol.142 (5), p.429-436 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.048360 ;PMID: 32418446

Full text available

10
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation (New York, N.Y.), 2022-05, Vol.145 (18), p.e895-e1032 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/cir.0000000000001063 ;PMID: 35363499

Full text available

11
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations
Material Type:
Article
Add to My Research

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations

Circulation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502 [Peer Reviewed Journal]

2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022194 ;PMID: 27297342

Full text available

12
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Empagliflozin in Heart Failure with a Preserved Ejection Fraction

The New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189

Full text available

13
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Material Type:
Article
Add to My Research

Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study

European heart journal, 2021-01, Vol.42 (2), p.178-188 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa898 ;PMID: 33245749

Full text available

14
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

The New England journal of medicine, 2022-09, Vol.387 (12), p.1089-1098 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2206286 ;PMID: 36027570

Full text available

15
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.1757-1780 [Peer Reviewed Journal]

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.011 ;PMID: 35379504

Full text available

16
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Material Type:
Article
Add to My Research

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Journal of the American College of Cardiology, 2016-09, Vol.68 (13), p.1476-1488 [Peer Reviewed Journal]

Copyright Elsevier Limited Sep 27, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.05.011 ;PMID: 27216111

Full text available

17
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Material Type:
Article
Add to My Research

2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2022-05, Vol.79 (17), p.e263-e421 [Peer Reviewed Journal]

Copyright © 2022 American Heart Association, Inc., the American College of Cardiology Foundation, and the Heart Failure Society of America. Published by Elsevier Inc. All rights reserved. ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.12.012 ;PMID: 35379503

Full text available

18
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Material Type:
Article
Add to My Research

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

The New England journal of medicine, 2020-10, Vol.383 (15), p.1413-1424 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022190 ;PMID: 32865377

Full text available

19
Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction
Material Type:
Article
Add to My Research

Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction

Journal of the American College of Cardiology, 2024-04, Vol.83 (14), p.1348-1350 [Peer Reviewed Journal]

EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2024.01.033 ;PMID: 38569765

Full text available

20
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
Material Type:
Article
Add to My Research

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (16), p.1284-1294 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;2021 The Authors. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056824 ;PMID: 34459213

Full text available

Results 1 - 20 of 13,229  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (12,608)

Refine My Results

Creation Date 

From To
  1. Before 1976  (305)
  2. 1976 To 1987  (1,422)
  3. 1988 To 1999  (2,500)
  4. 2000 To 2012  (4,745)
  5. After 2012  (4,270)
  6. More options open sub menu

Language 

  1. English  (12,735)
  2. Japanese  (1,280)
  3. German  (131)
  4. French  (109)
  5. Portuguese  (94)
  6. Spanish  (89)
  7. Polish  (49)
  8. Swedish  (40)
  9. Norwegian  (39)
  10. Italian  (35)
  11. Russian  (32)
  12. Turkish  (16)
  13. Chinese  (15)
  14. Serbian  (3)
  15. Lithuanian  (1)
  16. More options open sub menu

Searching Remote Databases, Please Wait